OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample collection solutions. OraSure, together with its subsidiaries, DNA Genotek and Sherlock Biosciences, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Our portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers.
DMS Imaging
DMS Imaging is focused on the development, design and manufacturing of medical imaging systems, mainly for digital radiology and bone densitometry, with its flagship production center located in the South of France (Gallargues-le-Montueux). With over 40 years of experience, DMS Imaging has established a network of 140 distributors across the globe and several major OEM partnerships, including Fujifilm, Canon Medical Systems Europe and Carestream, bringing an international dimension to the quality of its products. DMS Imaging offers a complete range of imaging systems on the international market. With its award-winning R/F solution, the Platinum Neo, and its bone densitometry solutions, Stratos and Stratos dR, DMS Imaging has established itself as a key player in the R/F and bone densitometry markets. Focused on bringing “intelligence to imaging,” DMS Imaging’s software platform, ADAM, offers unique functions and improved workflow. It is currently featured on the R/F, Mobile and C-Arm product lines. DMS Imaging is referenced by major French purchasing groups: UGAP, Resah and UniHA, and is a member of the French Healthcare Association, which promotes French excellence in healthcare. DMS Imaging won the JFR Innovation Award in 2021 for its R/F solution, the Platinum Neo, and in 2024 for its X-ray mobile system, Onyx.
DK Medical Systems
DK Medical Systems is a medical device manufacturer specializing in diagnostic radiology systems and imaging technology.
Discovery to Impact, University of Texas at Austin
The Discovery to Impact team at The University of Texas at Austin brings research discoveries to the marketplace to impact the world. Working with world-class inventors, investors, creators and entrepreneurs, we launch startups and collaborate with established businesses to accelerate new products, services, solutions and cures. We deliver results to contribute to UT Austin’s mission to be the world’s highest-impact public research university, unleashing knowledge, opportunity and innovation from the heart of Texas. And we relentlessly pursue our part of fulfilling UT’s promise: What starts here changes the world
DIMA Biotechnology LLC
DIMA Biotechnology LLC accelerates cancer research through innovative membrane protein and monoclonal antibody discovery platforms. We specialize in producing full length, hard-to-express targets such as GPCRs, ion channels, and transporters et al. All our proteins are overexpressed in HEK293 cells to ensure high quality expression with correct PTMS. Our proprietary platforms include: – Synthetic Nanodisc, PeptiNanodisc, and Detergent-based systems: providing pure full length transmembrane proteins purified by affinity chromatography. – VLP (Virus Like Particles), MNP (Membrane Nano Particles), and Exosome-based systems—which present proteins in their native context but are not purified proteins. We offer over 500 Nanodisc products, with 300+ available in stock for next day delivery covering many GPCR and channel proteins. In antibody discovery, we provide both single B cell–derived rabbit mAbs and Nanobody development. We offer 5,000+ prevalidated recombinant mAb sequences targeting 500+ cancer relevant proteins, which are ready for out-licensing and testing. Additional IgG candidates can be screened within six weeks using proprietary B cell libraries. Our mammalian cell display platform supports antibody engineering services including humanization, affinity maturation, and functional screening. DIMA delivers integrated solutions from membrane protein production to antibody optimization to advance cancer research and therapeutic development.
Digitec Srl
We design and customise software systems to acquire, process, display and manage X-ray images. We design and develop algorithm libraries for integration in different acquisition software, improving their efficiency and potential.
Detection Technology
For people’s health and safety, we equip X-ray systems with high-quality detector solutions and service. Our trusted solutions are the first choice for medical, security, and industrial imaging. We enable one-stop shopping for all detector needs—that makes us unique. We offer off-the-shelf and customized detectors for original equipment manufacturers (OEMs) and system integrators. Our solutions range from sensor components to optimized detector subsystems with ASICs, electronics, mechanics, software, and algorithms. Our solutions meet the performance and reliability requirements of the most stringent applications, such as high-end computed tomography (CT) systems. We have what it takes to become a forerunner in photon-counting CT (PCCT) imaging as we are pioneers in PC and CT detectors. Furthermore, our products are built on modular, scalable and easily customizable platforms. We know that tiny details done right make a big difference, and that’s why we are always pushing the edge of design for improved quality. When it comes to people’s health and safety, only reliable and robust solutions are acceptable. Over two billion inspections are carried out daily using our technology, and the number is growing rapidly. We are known as a company providing the best-in-class X-ray imaging solutions, service, and flexibility for a unique customer experience, always.
Destination Medical Center, EDA
Destination Medical Center (DMC) is a unique 20-year economic development initiative. The $5.6 billion plan is the largest in Minnesota’s history. With the expansion of Mayo Clinic and DMC growth, Rochester is a global destination for health and wellness and so much more. Rochester, Minnesota is its own special place. It spawned the world-renowned Mayo Clinic, home to those leading the way in life science discoveries and health care innovations. It’s the place people go to get better. Where developers are building an epicenter fueled by economic boom and dramatic growth. Where entrepreneurs come to find their place and discover the next big thing. The Destination Medical Center (DMC) initiative puts you in the middle of it all. | The DMC Initiative serves as a public-private partnership, combining private development by Mayo Clinic and other developers, as well as public funding from the City of Rochester, Olmsted County, and the State of Minnesota to facilitate and support public infrastructure. DMC promotes the City of Rochester, and more broadly, the County, and the State as a world destination medical center, to assist the patients, caregivers, residents, employees, and visitors in fully experiencing Rochester as a premier destination medical center, while providing extended economic development and opportunities for the City, the region, and the State.